UCB Pins Growth Hopes On Burgeoning Late-Stage Pipeline
Painful Skin Abscesses, Myasthenia Gravis And Refractory Epilepsy Targeted
UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.

UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.